Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Allstate Corp

Allstate Corp lessened its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 8.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 223,428 shares of the real estate investment trust’s stock after selling 20,206 shares during the period. Allstate Corp’s holdings in Healthpeak Properties were worth $4,529,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Harvest Fund Management Co. Ltd purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at approximately $30,000. Groupama Asset Managment bought a new position in Healthpeak Properties during the 3rd quarter valued at $37,000. Continuum Advisory LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $44,000. AdvisorNet Financial Inc raised its stake in shares of Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 563 shares in the last quarter. Finally, Kestra Investment Management LLC bought a new position in shares of Healthpeak Properties during the fourth quarter worth about $45,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DOC has been the topic of several research reports. Wedbush cut their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Mizuho dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Wells Fargo & Company decreased their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. Finally, Robert W. Baird lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average price target of $23.92.

Healthpeak Properties Stock Performance

DOC opened at $20.20 on Friday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The business’s 50 day moving average is $20.23 and its 200-day moving average is $21.11. The stock has a market cap of $14.13 billion, a PE ratio of 57.70, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a twelve month low of $17.80 and a twelve month high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were paid a dividend of $0.305 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.22 annualized dividend and a yield of 6.04%. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s payout ratio is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.